Andrew MK Pennell
Inventor
Stats
- 2 US patents issued
- 44 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 2 US Patents Issued
- 44 US Applications Filed
- 350 Total Citation Count
- Jan 10, 2020 Most Recent Filing
- Jun 11, 2003 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| CHEMOCENTRYX, INC. | 2
2 2 10 5 3 6 4 1 2 2 1 | 2003
2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2016 |
Inventor Addresses
| Address | Duration |
|---|---|
| San Francisco, CA | Aug 19, 04 - Dec 04, 08 |
| San Francisco, CA, US | Apr 29, 04 - May 14, 20 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61F: | FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS | 1 |
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 41 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 16 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2020/0147,066 | 2020 | Heteroaryl Sulfonamides and CCR2/CCR9 | 0 |
| 2019/0167,651 | 2019 | HETEROARYL SULFONAMIDES AND CCR2/CCR9 | 0 |
| 2018/0250,293 | 2018 | AZAINDAZOLE COMPOUNDS AND METHODS OF USE | 0 |
| 2017/0095,458 | 2017 | HETEROARYL SULFONAMIDES AND CCR2/CCR9 | 9 |
| 2015/0018,337 | 2015 | N-(2-(HETARYL)ARYL)ARYLSULFONAMIDES AND N-(2-(HETARYL)HETARYL)ARYLSULFONAMIDES | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.